Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers
US-2022003749-A1 · Jan 6, 2022 · US
This page is not indexed by search engines while we improve data quality.
Patent family 53274285
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 53274285 |
| Family type | — |
| Earliest priority | Dec 6, 2013 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US2022003749A1 — Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers |
Representative publication
Best representative member for this family based on priority and filing country.
US2022003749A1 — Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers (published Jan 6, 2022)
Member publications
Related publications in this family.
Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers
US-10996215-B2 · May 4, 2021 · US
Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers
US-2019004033-A1 · Jan 3, 2019 · US
Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers
US-2016313300-A1 · Oct 27, 2016 · US